RET Fusion Testing in Patients With NSCLC: The RETING Study

Autor: Esther Conde, MD, PhD, Susana Hernandez, PhD, Jose Luis Rodriguez Carrillo, MD, Rebeca Martinez, APT, Marta Alonso, APT, Daniel Curto, MD, Beatriz Jimenez, MD, Alejandra Caminoa, MD, PhD, Amparo Benito, MD, Pilar Garrido, MD, PhD, Sergi Clave, PhD, Edurne Arriola, MD, PhD, Isabel Esteban-Rodriguez, MD, PhD, Javier De Castro, MD, PhD, Irene Sansano, MD, Enriqueta Felip, MD, PhD, Federico Rojo, MD, PhD, Manuel Dómine, MD, PhD, Ihab Abdulkader, MD, PhD, Jorge Garcia-Gonzalez, MD, Cristina Teixido, PhD, Noemi Reguart, MD, PhD, Desamparados Compañ, MD, PhD, Amelia Insa, MD, Nuria Mancheño, MD, PhD, Sarai Palanca, MD, PhD, Oscar Juan-Vidal, MD, PhD, Nuria Baixeras, MD, Ernest Nadal, MD, PhD, Maria Cebollero, MD, Antonio Calles, MD, Paloma Martin, MD, PhD, Clara Salas, MD, PhD, Mariano Provencio, MD, PhD, Ignacio Aranda, MD, PhD, Bartomeu Massuti, MD, Laura Lopez-Vilaro, MD, Margarita Majem, MD, PhD, Luis Paz-Ares, MD, PhD, Fernando Lopez-Rios, MD, PhD

Publikováno v: JTO Clinical and Research Reports, Vol 5, Iss 4, Pp 100653- (2024)

Introduction: RET inhibitors with impressive overall response rates are now available for patients with NSCLC, yet the identification of RET fusions remains a difficult challenge. Most guidelines encourage the upfront use of next-generation sequencin

Externí odkaz: https://doaj.org/article/a3e58ca9d39948fda3972ff1d75a8f34

Utility of the Biomarker CA125 in the Diagnosis of Cellular Rejection in Allogeneic Heart Transplantation

Autor: López-Vilella, Raquel, Sánchez-Lázaro, Ignacio, Aguado, Carmen, Franch, Nuria Mancheño, Laiz, Begoña, Dolz, Luis Martínez, Bonet, Luis Almenar

Publikováno v: In Transplantation Proceedings November 2021 53(9):2721-2723

Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for

Autor: Javier, Simarro, Gema, Pérez-Simó, Nuria, Mancheño, Emilio, Ansotegui, Carlos Francisco, Muñoz-Núñez, José, Gómez-Codina, Óscar, Juan, Sarai, Palanca

Publikováno v: International journal of molecular sciences. 23(15)

In pretreatment tumor samples of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0bcff2a909df5d8f9fd4c4eb100494f5
https://pubmed.ncbi.nlm.nih.gov/35955661

Fenotipo cardiológico de la glucogenosis tipo XV: una miocardiopatía muy infrecuente a tener en cuenta

Autor: Nuria Mancheño, Luis Martínez-Dolz, Aitana Braza-Boïls, Nuria Muelas, Esther Zorio, Ismael Ejarque-Doménech

Publikováno v: Revista Española de Cardiología. 74:99-101

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a8ee154285bdbe72015f801c8d799b07
https://doi.org/10.1016/j.recesp.2020.05.033

Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation

Autor: Oscar Juan, Sarai Palanca, C. Jordá, Antonio Cremades, Emilio Ansotegui, José J. Cerón, Carolina Gandía, Rosa Farràs, José Miguel Pardo-Sánchez, Nuria Mancheño

Publikováno v: Cancers
Cancers, Vol 13, Iss 2980, p 2980 (2021)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Volume 13
Issue 12
r-FISABIO. Repositorio Institucional de Producción Científica
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Universitat Rovira i virgili (URV)

Simple Summary Advances have been made in the study of NSCLC tumors using in vivo models, such as patient-derived xenografts (PDXs). However, the number of PDX models that can represent the heterogeneity of NSCLC between different individuals is stil

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c0810f4863e8342bb7c4848b29f5510
https://pubmed.ncbi.nlm.nih.gov/34638519